Lexaria Bioscience Corp.: Lexaria Grants License to AnodGen Bioceuticals

DehydraTECH Pharmaceutical License Issued for the European, Australian and New Zealand marketsLexaria to receive royalty revenue from DehydraTECH product salesKELOWNA, BC / ACCESSWIRE / June 8, 2022 /

Related Keywords

Australia ,New Zealand ,Ireland ,United Kingdom ,Australian ,Andogen Bioceuticals ,George Jurcic ,Anodgen Bioceuticals ,Jeffrey Pruski ,Slimane Aboulkacem ,Exchange Commission ,Lexaria Pharmaceutical Corp ,Lexaria Bioscience Corp ,Company Or Lexaria ,Drug Administration ,Nasdaq ,License Issued ,Lexaria Bioscience ,Lexaria Pharmaceutical ,Bring Science ,Founding Member ,Chief Medical Officer ,Lexaria ,Ioscience ,Orp ,Migrants ,License ,Nodgen ,Ioceuticals ,